| pubmed-article:19041835 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C1556084 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0002006 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0961485 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:19041835 | lifeskim:mentions | umls-concept:C0449255 | lld:lifeskim |
| pubmed-article:19041835 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:19041835 | pubmed:dateCreated | 2008-12-1 | lld:pubmed |
| pubmed-article:19041835 | pubmed:abstractText | The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) randomized clinical trial demonstrated the efficacy of eplerenone, a new aldosterone antagonist diuretic, with standard treatment versus standard treatment alone in the reduction of cardiovascular mortality and cardiovascular-related hospital readmissions for patients with heart failure after an acute myocardial infarction. | lld:pubmed |
| pubmed-article:19041835 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19041835 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19041835 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19041835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19041835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19041835 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19041835 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19041835 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19041835 | pubmed:issn | 1875-2136 | lld:pubmed |
| pubmed-article:19041835 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:19041835 | pubmed:author | pubmed-author:SolesseAnneA | lld:pubmed |
| pubmed-article:19041835 | pubmed:author | pubmed-author:BeillatMaudM | lld:pubmed |
| pubmed-article:19041835 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19041835 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:19041835 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19041835 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19041835 | pubmed:pagination | 515-21 | lld:pubmed |
| pubmed-article:19041835 | pubmed:dateRevised | 2011-4-25 | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:meshHeading | pubmed-meshheading:19041835... | lld:pubmed |
| pubmed-article:19041835 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:19041835 | pubmed:articleTitle | Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study. | lld:pubmed |
| pubmed-article:19041835 | pubmed:affiliation | Health Economics, ESSEC, avenue Bernard-Hirsch, BP 50105, 95021 Cergy-Pontoise cedex, France. pouvourville@essec.fr | lld:pubmed |
| pubmed-article:19041835 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19041835 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19041835 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
